Taro Pharmaceutical Industries Ltd. (TARO)

Jun 24, 2024 - TAR was delisted (reason: acquired by Sun Pharma)

42.97

0.00 (0.00%)

Inactive · Last trade price on Jun 21, 2024

TARO Financials Overview

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '24 Mar 31, 2024	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Revenue	629.18	629.18	572.95	561.35	548.97	644.77
Revenue Growth	9.81%	9.81%	2.07%	2.25%	-14.86%	-3.75%
Gross Profit	304.96	304.96	268.32	293.12	296.66	399.73
Operating Income	21.49	21.49	17.71	67.69	-410.88	249.55
Net Income	53.87	53.87	25.45	58.27	-386.65	244.24
Earnings Per Share	1.43	1.43	0.68	1.55	-10.12	6.35
EPS Growth	110.29%	110.29%	-56.13%	-	-	-12.17%

Cash & Debt

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '24 Mar 31, 2024	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Cash & Investments	879.35	879.35	850.29	820.75	1,024	1,109
Total Debt	0	0	0	0	0	0
Net Cash (Debt)	879.35	879.35	850.29	820.75	1,024	1,109
Net Cash Growth	3.42%	3.42%	3.60%	-19.82%	-7.67%	5.66%
Net Cash Per Share	23.40	23.40	22.62	21.80	26.79	28.83

Cash Flow & CapEx

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '24 Mar 31, 2024	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Operating Cash Flow	124.56	124.56	31.75	-158.7	45.77	271.61
Capital Expenditures	-53.97	-53.97	-17.55	-11.8	-16.99	-26.63
Free Cash Flow	70.58	70.58	14.2	-170.5	28.78	244.97
Free Cash Flow Growth	397.18%	397.18%	-	-	-88.25%	-17.43%

Margins

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '24 Mar 31, 2024	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Gross Margin	48.47%	48.47%	46.83%	52.22%	54.04%	62.00%
Operating Margin	3.41%	3.41%	3.09%	12.06%	-74.85%	38.70%
Pretax Margin	13.14%	13.14%	6.67%	13.87%	-68.67%	46.18%
Profit Margin	8.56%	8.56%	4.44%	10.38%	-70.43%	37.88%
FCF Margin	11.22%	11.22%	2.48%	-30.37%	5.24%	37.99%

Valuation

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct '26 Oct 12, 2026	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
PE Ratio	30.05	29.54	35.92	27.91	-	9.66
P/FCF Ratio	22.88	22.55	64.39	-	98.05	9.63
PS Ratio	2.57	2.53	1.60	2.90	5.14	3.66